Journey Medical Corporation announced that Ernest (Ernie) De Paolantonio has notified the Company that, effective January 27, 2023, he will step down as Chief Financial Officer of Journey Medical to pursue another opportunity. The Company also announced the appointment of Joseph M. Benesch as Interim Chief Financial Officer, effective January 27, 2023. Mr. Benesch has served as the Company's Corporate Controller since November 2021.

He has over 25 years of experience in all aspects of financial reporting, technical accounting, corporate controllership, regulatory compliance and pharmaceutical company operations. Mr. Benesch previously served as the Principal Accounting Officer, Vice President and Corporate Controller of Teligent Pharma Inc., a specialty generic pharmaceutical company, and Corporate Controller of Torrent Pharmaceuticals, aU.S. subsidiary of the Torrent Group, a multinational pharmaceutical company. Before joining Torrent, he held senior financial management positions of increasing responsibility from Corporate Controller to Vice President of Finance at Savient Pharmaceuticals, Adare Pharmaceuticals and Edenbridge Pharmaceuticals.

Mr. Benesch's expertise includes building and leading finance teams and preparing SEC and GAAP compliant financial statements, and Sarbanes Oxley implementation. Mr. Benesch began his career in the public accounting sector at Baker Tilly Virchow Krause, LLP, and Ernst and Young working with a diverse client base. Mr. Benesch is a graduate of Wilkes University where he earned a BA in accounting and is a Certified Public Accountant.

To ensure a smooth transition, Mr. De Paolantonio will consult with and advise the Company through March 31, 2023.